Greater Vancouver / http://www.bcbliss.com
The Canadian cannabis sector is expanding as the federal government moves towards legalization of cannabis for recreational purposes in the summer of 2018. The effect of this step will be to create a projected supply shortfall of 40%. The estimated demand for medicinal cannabis is at $2.1 billion and recreational $10.0 billion.
Health Canada is the federal regulator which reviews and approves Licensed Producers and Licensed Sellers which are the required licenses to legally operate in the cannabis sector in Canada. As at December 31, 2017, Health Canada has approved 84 Licensed Producers, with over half of these being approved in 2017.
The Company commenced the licensing application process in 2015 and is now in the Detailed Active Review stage of the Health Canada process. Concurrent with working with Health Canada to be granted its License to Produce, the Company will undertake to raise $24 million (in a combination of equity and debt) to build out and equip its growing facility, based in Greater Vancouver.
Funds raised from this financing will enable the Company to continue with the Health Canada licensing process and if the maximum raise is attained, to accelerate the steps required to complete the construction of the growing facility.
Here's how BCBliss Bioceuticals Corp. is planning on using the funds raised from this crowdfunding:
| Minimum Raise | Maximum Raise | |
| Legal and consulting fees • City of Richmond – Building Permit | N/A | 10,000 |
| Complete architectural drawings | N/A | 7,500 |
| Property Assessment/Re-valuation fees | N/A | 10,000 |
| Additional Fund raising $15 million raise for build out and equipping the facility | N/A | 15,000 |
| • Accounting and audits | N/A | 2,500 |
| • Legal | N/A | 5,000 |
| • Management Fees and Expenses | N/A | 30,000 |
| • Marketing | N/A | 10,000 |
| Technical writing to support License to Produce and License to Grow | 5,000 | 10,000 |